Stocks to sell

For the first half of 2019, the Cisco (NASDAQ:CSCO) turnaround looked like it was finally going to happen. That is, the legacy tech giant was revamping itself through various cloud, automation, security and collaboration initiatives. Those initiatives were gaining traction, and Cisco’s revenue, margin, and profit growth trends were materially improving. Overall, Cisco stock was

There are two big questions on every investor’s mind as we enter the new year. First, what are the stocks to buy in 2020? Second, what are the stocks to sell in 2020? I’ve already attempted to answer the first question for you in my gallery on the top stocks to buy for 2020. To

Aurora Cannabis (NYSE:ACB) stock is at a crossroads. The cannabis company isn’t expected to become profitable any time soon. That means the company will continue to bleed cash flow, and ACB stock could drop further. Source: Shutterstock Moreover, some believe Aurora stock is likely to fall below $1, a key threshold. Many investors don’t want

If for nothing else than its dramatic valuation swing, FuelCell Energy (NASDAQ:FCEL) has suddenly become a hot commodity. Since the beginning of November, FCEL stock has jumped almost 700%, easily putting a smile on long embattled shareholders’ faces. But does this alternative energy company have the goods to sustain its resurgence into 2020? Source: Shutterstock

Bank of America (NYSE:BAC), arguably Warren Buffett’s favorite bank stock, surged 43% in 2019 as investors applauded the bank’s conservative management and better-than-expected quarterly results. Lately, though, the banking sector and Bank of America  stock can’t catch a break. Source: Michael Vi / Shutterstock.com Recent notes to clients from UBS, Baird, and Keefe, Bruyette &

Recognizing that the future of media consumption is online, little-known Indian entertainment company Eros (NYSE:EROS) has tried to aggressively transform from an antiqued film business into a next-gen, hyper-growth streaming content business, something like the Netflix (NASDAQ:NFLX) of India. Source: Shutterstock.com But Eros hasn’t turned into the Netflix of India. Instead, EROS stock has plunged

InvestorPlace’s Josh Enomoto recently called Naked Brand Group (NASDAQ:NAKD) “almost completely irrelevant.” I would go a step further and suggest NAKD stock should not be traded on the public markets. Source: Shutterstock Seriously, why is Naked Brand still a public company? Anybody? There Are Countless Better Options Than NAKD I did a quick screen of

In October, Teva Pharmaceuticals (NYSE:TEVA) stock hit a 20-year low, reaching about $6.50 per share. Keep in mind that in 2015 the stock price was $70. Source: JHVEPhoto / Shutterstock.com Yes, it has been an absolute disaster. Teva, which was launched in Israel in 1901, was once seemingly invincible. Now the company is desperately trying

Pfizer (NYSE:PFE) has been working on its recovery over the past six months as it climbs from its August lows. Despite rallying more than 15% from those lows, Pfizer stock is still down more than 13% from its fourth quarter 2018 highs. Is it time to bet on Pfizer stock or throw in the towel?

When I last weighed in on Nio (NYSE:NIO) it looked as if the company was entering the beginning of the end. Nio stock seemed like the worst buy possible. Source: Carrie Fereday / Shutterstock.com “I’m not a fan of the stock with the EV market pulling back,” I wrote. “You can find better opportunities elsewhere

Shares in Grubhub (NYSE:GRUB) rose recently on hopes the company will be bought. Then the company denied the report and the shares went back down. Source: Lori Butcher / Shutterstock.com Grubhub, a restaurant delivery service that went public in 2014, saw shares peak in 2018 at $146 each, but they opened Jan. 10 at $51.34

Penny stocks are almost always high-risk, high-reward investments. Some of them are worth buying because they have visible and realistic pathways to at least tripling. Source: Tinseltown / Shutterstock.com That’s why I’ve recommended some penny stocks before, like struggling department store operator Stage Stores (NYSE:SSI), Chinese premium electric vehicle maker NIO (NYSE:NIO), and hydrogen fuel

As with many other stocks in 2019, General Electric (NYSE:GE) ended with a nice bullish move. Starting in early October, shares of GE stock went from $8.28 to around $12 per share. This put the year-long return for 2019 at about 53%, which exceeded the gain on the S&P 500. Source: testing / Shutterstock.com This

For oil and gas investors, 2019 was an awful year. While a few of the integrated major oil companies managed to scratch out modest gains, nearly all of the smaller companies suffered sickening losses. For Cheasapeake (NSYE:CHK) it was even worse, as CHK stock price tumbled by two-thirds in 2019. The fact that the overall

Are stocks like Hexo (NASDAQ:HEXO) and Aurora Cannabis (NYSE:ACB) canaries in the coal mine? Is the underperformance from Hexo stock and Aurora a warning shot to the rest of the cannabis group, or are they simply laggards in the industry? Source: Shutterstock The cannabis sector bottomed in November, as a majority of the group ended

It’s been the best of times and the worst of times for Johnson & Johnson (NYSE:JNJ) stock. On the one hand, considering that much of its revenue comes from low-growth consumer staples or medical devices, the company’s revenue and profits are actually rising fairly rapidly. That’s partly because its pharma unit’s drugs are selling well.

Many investors regard Canada-based Canopy Growth (NYSE:CGC) as one of the best cannabis companies. CGC is the largest marijuana stock by market cap. But in 2019, its large size  did not help support Canopy Growth stock, as the shares fell 21% last year. Source: Shutterstock Although 2020 may turn out to be a better year for

How low is the bar for Canadian pot stocks that the media celebrate Aphria (NYSE:APHA) for being the first in the sector to post two profitable quarters in a row? It’s pretty low. Source: Shutterstock Aphria stock may be the best house on the block in the Canadian pot business. However, investors can’t forget that it is

Among the social media operators, Snap (NYSE:SNAP) stock was one of the standouts in the last year.  In the last 12 months, Snapchat stock has surged by a sizzling 170%, putting its market cap at $23.5 billion. Source: dennizn / Shutterstock.com But it’s important to keep things in perspective. The company went public in March

Unlike other mainstream investment sectors that at least have a semblance of predictability, the pharmaceutical industry is notoriously volatile. Case in point is Amarin (NASDAQ:AMRN). Specializing in an omega-3-based treatment called Vascepa, the drug is designed as an ancillary treatment to reduce cardiovascular events for patients with elevated triglyceride levels. Source: Pavel Kapysh / Shutterstock.com